CCDC12 gene methylation in peripheral blood as a potential biomarker for breast cancer detection

References

• Al Sarakbi W, Sasi W, Jiang WG, Roberts T, Newbold RF, Mokbel K. 2009. The mRNA expression of SETD2 in human breast cancer: correlation with clinico-pathological parameters. BMC Cancer. 9(1):290. doi: 10.1186/1471-2407-9-290
   PubMedGoogle Scholar
• Bertoli G, Cava C, Castiglioni I. 2015. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 5(10):1122–1143. doi: 10.7150/thno.11543
   PubMed Web of Science ®Google Scholar
• Boyne DJ, Friedenreich CM, McIntyre JB, Stanczyk FZ, Courneya KS, King WD. 2017. Endogenous sex hormone exposure and repetitive element DNA methylation in healthy postmenopausal women. Cancer Causes Control. 28(12):1369–1379. doi: 10.1007/s10552-017-0958-z
   PubMed Web of Science ®Google Scholar
• Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. 2024. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 74(3):229–263. doi: 10.3322/caac.21834
   PubMed Web of Science ®Google Scholar
• Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan MM, Senn HJ, Winer EP, Gnant M. 2021. Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021. Ann Oncol. 32(10):1216–1235. doi: 10.1016/j.annonc.2021.06.023
   PubMed Web of Science ®Google Scholar
• Campan M, Weisenberger DJ, Laird PW. 2006. DNA methylation profiles of female steroid hormone-driven human malignancies. Curr Top Microbiol Immunol. 310:141–178. doi: 10.1007/3-540-31181-5_8
   PubMed Web of Science ®Google Scholar
• Chen X, Dong Z, Hubbell E, Kurtzman KN, Oxnard GR, Venn O, Melton C, Clarke CA, Shaknovich R, Ma T, et al. 2021. Prognostic significance of blood-based multi-cancer detection in plasma cell-free DNA. Clin Cancer Res. 27(15):4221–4229. doi: 10.1158/1078-0432.CCR-21-0417
   PubMed Web of Science ®Google Scholar
• Costa-Pinheiro P, Montezuma D, Henrique R, Jerónimo C. 2015. Diagnostic and prognostic epigenetic biomarkers in cancer. Epigenomics. 7(6):1003–1015. doi: 10.2217/epi.15.56
   PubMed Web of Science ®Google Scholar
• Dong L, Ren H. 2018. Blood-based DNA methylation biomarkers for early detection of colorectal cancer. J Proteomics Bioinform. 11(6):120–126. doi: 10.4172/jpb.1000477
   PubMedGoogle Scholar
• Du F, Peng L, Wang Q, Dong K, Pei W, Zhuo H, Xu T, Jing C, Li L, Zhang J, et al. 2022. CCDC12 promotes tumor development and invasion through the Snail pathway in colon adenocarcinoma. Cell Death Dis. 13(3):273. doi: 10.1038/s41419-022-04617-y
   PubMed Web of Science ®Google Scholar
• Ennour-Idrissi K, Dragic D, Durocher F, Diorio C. 2020. Epigenome-wide DNA methylation and risk of breast cancer: a systematic review. BMC Cancer. 20(1):1048. doi: 10.1186/s12885-020-07543-4
   PubMed Web of Science ®Google Scholar
• Fan C, Dong L, Zhu N, Xiong Y, Zhang J, Wang L, Shen Y, Zhang X, Chen M. 2012. Isolation of siRNA target by biotinylated siRNA reveals that human CCDC12 promotes early erythroid differentiation. Leuk Res. 36(6):779–783. doi: 10.1016/j.leukres.2011.12.017
   PubMed Web of Science ®Google Scholar
• Győrffy B, Bottai G, Fleischer T, Munkácsy G, Budczies J, Paladini L, Børresen-Dale A-L, Kristensen VN, Santarpia L. 2016. Aberrant DNA methylation impacts gene expression and prognosis in breast cancer subtypes. Int J Cancer. 138(1):87–97. doi: 10.1002/ijc.29684
   PubMed Web of Science ®Google Scholar
• Harbs J, Rinaldi S, Keski-Rahkonen P, Liu X, Palmqvist R, Van Guelpen B, Harlid S. 2023. An epigenome-wide analysis of sex hormone levels and DNA methylation in male blood samples. Epigenetics. 18(1):2196759. doi: 10.1080/15592294.2023.2196759
   PubMed Web of Science ®Google Scholar
• Henriksen SD, Madsen PH, Krarup H, Thorlacius-Ussing O. 2015. DNA hypermethylation as a blood-based marker for pancreatic cancer: a literature review. Pancreas. 44(7):1036–1045. doi: 10.1097/MPA.0000000000000487
   PubMed Web of Science ®Google Scholar
• Hoebeeck J, Michels E, Menten B, Van Roy N, Eggert A, Schramm A, De Preter K, Yigit N, De Smet E, De Paepe A, et al. 2007. High resolution tiling-path BAC array deletion mapping suggests commonly involved 3p21-p22 tumor suppressor genes in neuroblastoma and more frequent tumors. Int J Cancer. 120(3):533–538. doi: 10.1002/ijc.22326
   PubMed Web of Science ®Google Scholar
• Jacobs AT, Martinez Castaneda-Cruz D, Rose MM, Connelly L. 2022. Targeted therapy for breast cancer: An overview of drug classes and outcomes. Biochem Pharmacol. 204:115209. doi: 10.1016/j.bcp.2022.115209
   PubMed Web of Science ®Google Scholar
• Jafari SH, Saadatpour Z, Salmaninejad A, Momeni F, Mokhtari M, Nahand JS, Rahmati M, Mirzaei H, Kianmehr M. 2018. Breast cancer diagnosis: imaging techniques and biochemical markers. J Cell Physiol. 233(7):5200–5213. doi: 10.1002/jcp.26379
   PubMed Web of Science ®Google Scholar
• Jatoi I, Anderson WF. 2010. Qualitative age interactions in breast cancer studies: a mini-review. Future Oncol. 6(11):1781–1788. doi: 10.2217/fon.10.139
   PubMed Web of Science ®Google Scholar
• Jensen SØ, Øgaard N, Ørntoft M-BW, Rasmussen MH, Bramsen JB, Kristensen H, Mouritzen P, Madsen MR, Madsen AH, Sunesen KG, et al. 2019. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study. Clin Epigenetics. 11(1):158. doi: 10.1186/s13148-019-0757-3
   PubMed Web of Science ®Google Scholar
• Jiang G-Y, Zhang X-P, Zhang Y, Xu H-T, Wang L, Li Q-C, Wang E-H. 2016. Coiled-coil domain-containing protein 8 inhibits the invasiveness and migration of non-small cell lung cancer cells. Hum Pathol. 56:64–73. doi: 10.1016/j.humpath.2016.06.001
   PubMed Web of Science ®Google Scholar
• Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, et al. 2011. DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables. Mol Oncol. 5(1):77–92. doi: 10.1016/j.molonc.2010.11.002
   PubMed Web of Science ®Google Scholar
• Ke J, Lou J, Zhong R, Chen X, Li J, Liu C, Gong Y, Yang Y, Zhu Y, Zhang Y, et al. 2016. Identification of a potential regulatory variant for colorectal cancer risk mapping to 3p21.31 in Chinese population. Sci Rep. 6(1):25194. doi: 10.1038/srep25194
   PubMedGoogle Scholar
• Kim DH, Binder AM, Zhou H, Jung SY. 2023. DNA methylation patterns associated with breast cancer prognosis that are specific to tumor subtype and menopausal status. Front Genet. 14:1133443. doi: 10.3389/fgene.2023.1133443
   PubMed Web of Science ®Google Scholar
• Laird PW. 2010. Principles and challenges of genomewide DNA methylation analysis. Nat Rev Genet. 11(3):191–203. doi: 10.1038/nrg2732
   PubMed Web of Science ®Google Scholar
• Li L, Choi J-Y, Lee K-M, Sung H, Park SK, Oze I, Pan K-F, You W-C, Chen Y-X, Fang J-Y, et al. 2012. DNA methylation in peripheral blood: a potential biomarker for cancer molecular epidemiology. J Epidemiol. 22(5):384–394. doi: 10.2188/jea.je20120003
   PubMed Web of Science ®Google Scholar
• Li Y, Fan Z, Meng Y, Liu S, Zhan H. 2023. Blood-based DNA methylation signatures in cancer: A systematic review. Biochim Biophys Acta Mol Basis Dis. 1869(1):166583. doi: 10.1016/j.bbadis.2022.166583
   PubMed Web of Science ®Google Scholar
• Liu Z, Yan W, Liu S, Liu Z, Xu P, Fang W. 2023. Regulatory network and targeted interventions for CCDC family in tumor pathogenesis. Cancer Lett. 565:216225. doi: 10.1016/j.canlet.2023.216225
   PubMed Web of Science ®Google Scholar
• Loke SY, Lee ASG. 2018. The future of blood-based biomarkers for the early detection of breast cancer. Eur J Cancer. 92:54–68. doi: 10.1016/j.ejca.2017.12.025
   PubMed Web of Science ®Google Scholar
• Mason JM, Arndt KM. 2004. Coiled coil domains: stability, specificity, and biological implications. Chembiochem. 5(2):170–176. doi: 10.1002/cbic.200300781
   PubMed Web of Science ®Google Scholar
• Nassar FJ, Chamandi G, Tfaily MA, Zgheib NK, Nasr R. 2020. Peripheral blood-based biopsy for breast cancer risk prediction and early detection. Front Med (Lausanne). 7:28. doi: 10.3389/fmed.2020.00028
   PubMed Web of Science ®Google Scholar
• Noroozi R, Ghafouri-Fard S, Pisarek A, Rudnicka J, Spólnicka M, Branicki W, Taheri M, Pośpiech E. 2021. DNA methylation-based age clocks: from age prediction to age reversion. Ageing Res Rev. 68:101314. doi: 10.1016/j.arr.2021.101314
   PubMed Web of Science ®Google Scholar
• Ouyang D, Yang P, Cai J, Sun S, Wang Z. 2020. Comprehensive analysis of prognostic alternative splicing signature in cervical cancer. Cancer Cell Int. 20(1):221. doi: 10.1186/s12935-020-01299-4
   PubMed Web of Science ®Google Scholar
• Pérez RF, Tejedor JR, Bayón GF, Fernández AF, Fraga MF. 2018. Distinct chromatin signatures of DNA hypomethylation in aging and cancer. Aging Cell. 17(3):e12744. doi: 10.1111/acel.12744
   PubMed Web of Science ®Google Scholar
• Priyanka PP, Yenugu S. 2021. Coiled-coil domain-containing (CCDC) proteins: functional roles in general and male reproductive physiology. Reprod Sci. 28(10):2725–2734. doi: 10.1007/s43032-021-00595-2
   PubMed Web of Science ®Google Scholar
• Rae DT, Hocum JD, Bii V, Deeg HJ, Trobridge GD. 2015. A novel retroviral mutagenesis screen identifies prognostic genes in RUNX1 mediated myeloid leukemogenesis. Oncotarget. 6(31):30664–30674. doi: 10.18632/oncotarget.5133
   PubMedGoogle Scholar
• Robertson KD. 2005. DNA methylation and human disease. Nat Rev Genet. 6(8):597–610. doi: 10.1038/nrg1655
   PubMed Web of Science ®Google Scholar
• Roy M, Fowler AM, Ulaner GA, Mahajan A. 2023. Molecular classification of breast cancer. PET Clin. 18(4):441–458. doi: 10.1016/j.cpet.2023.04.002
   PubMed Web of Science ®Google Scholar
• Sandström J, Balian A, Lockowandt R, Fornander T, Nordenskjöld B, Lindström L, Pérez-Tenorio G, Stål O. 2021. IP6K2 predicts favorable clinical outcome of primary breast cancer. Mol Clin Oncol. 14(5):94. doi: 10.3892/mco.2021.2256
   PubMed Web of Science ®Google Scholar
• Sher G, Salman NA, Khan AQ, Prabhu KS, Raza A, Kulinski M, Dermime S, Haris M, Junejo K, Uddin S, et al. 2022. Epigenetic and breast cancer therapy: promising diagnostic and therapeutic applications. Semin Cancer Biol. 83:152–165. doi: 10.1016/j.semcancer.2020.08.009
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Wagle NS, Jemal A. 2023. Cancer statistics, 2023. CA Cancer J Clin. 73(1):17–48. doi: 10.3322/caac.21763
   PubMed Web of Science ®Google Scholar
• Suijkerbuijk KPM, van Diest PJ, van der Wall E. 2011. Improving early breast cancer detection: focus on methylation. Ann Oncol. 22(1):24–29. doi: 10.1093/annonc/mdq305
   PubMed Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. 2021. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71(3):209–249. doi: 10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Tang Q, Cheng J, Cao X, Surowy H, Burwinkel B. 2016. Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics. 8(1):115. doi: 10.1186/s13148-016-0282-6
   PubMedGoogle Scholar
• Terp SK, Stoico MP, Dybkær K, Pedersen IS. 2023. Early diagnosis of ovarian cancer based on methylation profiles in peripheral blood cell-free DNA: a systematic review. Clin Epigenetics. 15(1):24. doi: 10.1186/s13148-023-01440-w
   PubMed Web of Science ®Google Scholar
• Tessema M, Yingling CM, Picchi MA, Wu G, Liu Y, Weissfeld JL, Siegfried JM, Tesfaigzi Y, Belinsky SA. 2015. Epigenetic repression of CCDC37 and MAP1B links chronic obstructive pulmonary disease to lung cancer. J Thorac Oncol. 10(8):1181–1188. doi: 10.1097/JTO.0000000000000592
   PubMed Web of Science ®Google Scholar
• Waks AG, Winer EP. 2019. Breast cancer treatment: a review. JAMA. 321(3):288–300. doi: 10.1001/jama.2018.19323
   PubMed Web of Science ®Google Scholar
• Worm Orntoft MB. 2018. Review of blood-based colorectal cancer screening: how far are circulating cell-free DNA methylation markers from clinical implementation? Clin Colorectal Cancer. 17(2):e415–e433. doi: 10.1016/j.clcc.2018.02.012
   PubMed Web of Science ®Google Scholar
• Wu Q, Odwin-Dacosta S, Cao S, Yager JD, Tang WY. 2019. Estrogen down regulates COMT transcription via promoter DNA methylation in human breast cancer cells. Toxicol Appl Pharmacol. 367:12–22. doi: 10.1016/j.taap.2019.01.016
   PubMed Web of Science ®Google Scholar
• Xu Z, Sandler DP, Taylor JA. 2020. Blood DNA methylation and breast cancer: a prospective case-cohort analysis in the sister study. J Natl Cancer Inst. 112(1):87–94. doi: 10.1093/jnci/djz065
   PubMedGoogle Scholar
• Zhou C, He X, Zeng Q, Zhang P, Wang CT. 2020. CCDC7 activates interleukin-6 and vascular endothelial growth factor to promote proliferation via the JAK-STAT3 pathway in cervical cancer cells. OncoTargets Ther. 13:6229–6244. doi: 10.2147/OTT.S244663
   PubMed Web of Science ®Google Scholar